![Thomas E. Newberry](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas E. Newberry
Geen lopende functies
Profiel
Thomas E.
Newberry is Vice President-Corporate Communications of GTC Biotherapeutics, Inc. He joined GTC Biotherapeutics in May 2000.
Mr. Newberry has more than 20 years of experience in investor relations, public relations, engineering, training and regulatory programs in the healthcare and power industries.
He received a BS in Mechanical Engineering from Rochester Institute of Technology.
Eerdere bekende functies van Thomas E. Newberry
Bedrijven | Functie | Einde |
---|---|---|
REVO BIOLOGICS INC | Public Communications Contact | - |
Opleiding van Thomas E. Newberry
Rochester Institute of Technology | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
rEVO Biologics, Inc.
![]() rEVO Biologics, Inc. BiotechnologyHealth Technology rEVO Biologics, Inc. engages in the development and commercialization of specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions. Its products include ATryn, which prevents blood clots during and after surgery and childbirth for patients with hereditary antithrombin deficiency. The company was founded in February 1993 and is headquartered in Framingham, MA. | Health Technology |